| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael David Garrison | EVP Pres Med.EssntlBioPharm | 2026-06-10 | 1,100 | $151.48 | $166.63kSell |
| Thomas E. Polen Jr. | Chairman CEO and President | 2026-06-01 | 20,209 | $126.16 | $2.55MBuy |
| Thomas E. Polen Jr. | Chairman CEO and President | 2026-06-01 | 17,445 | $146.15 | $2.55MSell |
| Thomas E. Polen Jr. | Chairman CEO and President | 2026-06-01 | 2,764 | $146.35 | $404.51kSell |
| Michael Feld | EVP Chief Revenue Officer | 2026-05-26 | 75 | $147.35 | $11.05kSell |
| Michael Feld | EVP Chief Revenue Officer | 2026-04-27 | 74 | $151.94 | $11.24kSell |
| Michael Feld | EVP Chief Revenue Officer | 2026-03-26 | 75 | $156.83 | $11.76kSell |
| Michael Feld | EVP Chief Revenue Officer | 2026-02-26 | 75 | $181.84 | $13.64kSell |
| Bertram L. Scott | Director | 2026-02-18 | 953 | $182.61 | $174.03kSell |
| Michael Feld | EVP CRO Pres. Life Sciences | 2026-01-26 | 75 | $202.73 | $15.20kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 9.49% | 26,153,411 | $3.87B | Institution |
| Vanguard Capital Management LLC | 6.71% | 18,490,610 | $2.73B | Institution |
| Vanguard Portfolio Management LLC | 5.56% | 15,317,242 | $2.26B | Institution |
| State Street Corp | 5.02% | 13,822,808 | $2.04B | Institution |
| First Eagle Investment Management LLC | 4.33% | 11,928,111 | $1.76B | Institution |
| Invesco Ltd | 3.69% | 10,174,327 | $1.50B | Institution |
| T Rowe Price Investment Management Inc | 3.52% | 9,685,271 | $1.43B | Institution |
| Massachusetts Financial Services Co | 3.30% | 9,101,454 | $1.35B | Institution |
| Geode Capital Management LLC | 2.58% | 7,107,263 | $1.05B | Institution |
| Wellington Management Group LLP | 2.40% | 6,615,230 | $977.66M | Institution |